EMMAC is bringing together the latest science and research into the medical benefits of cannabis with pioneering cultivation, extraction and production to establish itself as the European leader in the production and supply of medical cannabis.
EMMAC is at the forefront of the global medical cannabis industry working with research institutions to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential public health benefits for patients.
EMMAC announces pioneering research collaboration with Imperial College London
The partnership between EMMAC and Imperial College London has been forged to deliver a long-term comprehensive research programme designed to shape the future of the medical cannabis therapeutic industry.
EMMAC’s European Operations
EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.
EMMAC Across Europe
Events & Press Releases
Cannabis Europa London builds on the momentum of the inaugural Cannabis Europa conference in May 2018. The event saw over
EMMAC to partner with Hyris Ltd to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp
London, 24 June 2019: EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive
18 June 2019, London. EMMAC, the European independent medical cannabis company, is pleased to announce that construction has started on its planned EU-GMP facility in Malta. This follows the
Immediate access to French wellness market and established portfolio of hemp-based wellness products 11 June 2019, London. EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased